Quercetin Down-regulates IL-6/STAT-3 Signals to Induce Mitochondrial-mediated Apoptosis in a Non-small-cell Lung-cancer Cell Line, A549
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: Quercetin, a flavonoid compound, has been reported to induce apoptosis in cancer cells, but its anti-inflammatory effects, which are also closely linked with apoptosis, if any, on non-small-cell lung cancer (NSCLC) have not so far been critically examined. In this study, we tried to determine if quercetin had any demonstrable anti-inflammatory potential, which also could significantly contribute to inducing apoptosis in a NSCLC cell line, A549. Methods: In this context, several assays, including cytotoxicity, flow cytometry and fluorimetry, were done. Gene expression was analyzed by using a western blot analysis. Results: Results revealed that quercetin could induce apoptosis in A549 cells through mitochondrial depolarization by causing an imbalance in B-cell lymphoma 2/Bcl2 Antagonist X (Bcl2/Bax) ratio and by down-regulating the interleukine-6/signal transducer and activator of transcription 3 (IL-6/STAT3) signaling pathway. An analysis of the data revealed that quercetin could block nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) activity at early hours, which might cause a down-regulation of the IL-6 titer, and the IL-6 expression, in turn, could inhibit p-STAT3 expression. Down-regulation of both the STAT3 and the NF-κB expressions might, therefore, cause down-regulation of Bcl2 activity because both are major upstream effectors of Bcl2. Alteration in Bcl2 responses might result in an imbalance in the Bcl2/Bax ratio, which could ultimately bring about mitochondria mediated apoptosis in A549 cells. Conclusion: Overall, the finding of this study indicates that a quercetin induced anti-inflammatory pathway in A549 cells appeared to make a significant contribution towards induction of apoptosis in NSCLC and, thus, may have a therapeutic use such as a strong apoptosis inducer in cancer cells.
Abstract
Objectives: Quercetin, a flavonoid compound, has been reported to induce apoptosis in cancer cells, but its anti-inflammatory effects, which are also closely linked with apoptosis, if any, on non-small-cell lung cancer (NSCLC) have not so far been critically examined. In this study, we tried to determine if quercetin had any demonstrable anti-inflammatory potential, which also could significantly contribute to inducing apoptosis in a NSCLC cell line, A549. Methods: In this context, several assays, including cytotoxicity, flow cytometry and fluorimetry, were done. Gene expression was analyzed by using a western blot analysis. Results: Results revealed that quercetin could induce apoptosis in A549 cells through mitochondrial depolarization by causing an imbalance in B-cell lymphoma 2/Bcl2 Antagonist X (Bcl2/Bax) ratio and by down-regulating the interleukine-6/signal transducer and activator of transcription 3 (IL-6/STAT3) signaling pathway. An analysis of the data revealed that quercetin could block nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) activity at early hours, which might cause a down-regulation of the IL-6 titer, and the IL-6 expression, in turn, could inhibit p-STAT3 expression. Down-regulation of both the STAT3 and the NF-κB expressions might, therefore, cause down-regulation of Bcl2 activity because both are major upstream effectors of Bcl2. Alteration in Bcl2 responses might result in an imbalance in the Bcl2/Bax ratio, which could ultimately bring about mitochondria mediated apoptosis in A549 cells. Conclusion: Overall, the finding of this study indicates that a quercetin induced anti-inflammatory pathway in A549 cells appeared to make a significant contribution towards induction of apoptosis in NSCLC and, thus, may have a therapeutic use such as a strong apoptosis inducer in cancer cells.
참고문헌 (29)
- Ferlay J, "Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008", Int J Cancer, 127(12), pp.2893~2917 (2010)
- Ancuceanu RV, "Pharmacologically active natural compounds for lung cancer", Altern Med Rev, 9(4), pp.402~419 (2004)
- Ren W, "Flavonoids: promising anticancer agents", Med Res Rev, 23(4), pp.519~534 (2003)
- Li Y1, "Flavonoids from tartary buckwheat induce G2", M cell cycle arrest and apoptosis in human hepatoma HepG2 cells, 2014, pp.46(6), 460~470
- Mukherjee A, "Flavonol isolated from ethanolic leaf extract of Thuja occidentalis arrests the cell cycle at G2-M and induces ROS-independent apoptosis in A549 cells, targeting nuclear DNA", Cell Prolif, 47(1), pp.56~71 (2014)
- Youn H, "Quercetin potentiates apoptosis by inhibiting nuclear factor-kappaB signaling in H460 lung cancer cells", Biol Pharm Bull, 36(6), pp.944~951 (2013)
- Coussens LM, "Inflammation and cancer", Nature, 420(6917), pp.860~867 (2002)
- Balkwill F, "Inflammation and cancer: back to Virchow?", Lancet, 357(9255), pp.539~545 (2001)
- Hong DS, "Interleukin-6 and its receptor in cancer: implications for translational therapeutics", Cancer, 110(9), pp.1911~1928 (2007)
- Libermann TA, "Activation of interleukin-6 gene expression through the NF-kappa B transcription factor", Mol Cell Biol, 10(5), pp.2327~2334 (1990)
- Neurath MF, "IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer", Cytokine Growth Factor Rev, 22(2), pp.83~89 (2011)
- Yu H, "STATs in cancer inflammation and immunity: a leading role for STAT3", Nat Rev Cancer, 9(11), pp.798~809 (2009)
- Bromberg JF, "Stat3 as an oncogene", Cell, 98(3), pp.295~303 (1999)
- Stathopoulos GT, "Epithelial NF-kappaB activation promotes urethane-induced lung carcinogenesis", Proc Natl Acad Sci USA, 104(47), pp.18514~18519 (2007)
- Bhattacharya S, "STAT3-mediated transcription of Bcl-2, Mcl-1 and c-IAP2 prevents apoptosis in polyamine-depleted cells", Biochem J, 392, pp.335~344 (2005)
- Adams JM, "The Bcl-2 protein family: arbiters of cell survival", Science, 281(5381), pp.1322~1326 (1998)
- Murphy KM, "Bcl-2 inhibits Bax translocation from cytosol to mitochondria during drug-induced apoptosis of human tumor cells", Cell Death Differ, 7(1), pp.102~111 (2000)
- Prasad S, "Targeting inflammatory pathways by flavonoids for prevention and treatment of cancer", Planta Med, 76(11), pp.1044~1063 (2010)
- Chirumbolo S, "The role of quercetin, flavonols and flavones in modulating inflammatory cell function", Inflamm Allergy Drug Targets, 9(4), pp.263~285 (2010)
- Mosmann T, "Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays", J Immunol Methods, 65(1-2), pp.55~63 (1983)
- Darzynkiewicz Z, "Analysis of apoptosis by cytometry using TUNEL assay", Methods, 44(3), pp.250~254 (2008)
- Ganguly A, "Targeting mitochondrial cell death pathway to overcome drug resistance with a newly developed iron chelate", Plos One, 5(6), pp.e11253~ (2010)
- Sambrook J, "Molecular Cloning: A Laboratory Manual" (2001), Cold Spring Harbour Laboratory Press
- Phaneuf S, "Cytochrome c release from mitochondria in the aging heart: a possible mechanism for apoptosis with age", Am J Physiol Regul Integr Comp Physiol, 282(2), pp.423~430 (2002)
- Yu J, "Curcumin Induces Apoptosis Involving bax", bcl-2 in Human Hepatoma SMMC-7721 Cells, 2011, pp.12, 1925~1929
- Elmore S, "Apoptosis: a review of programmed cell death", Toxicol Pathol, 35(4), pp.495~516 (2007)
- Fagard R, "STAT3 inhibitors for cancer therapy: Have all roads been explored?", JAKSTAT, 2(1), pp.e22882~ (2013)
- Karin M, "NF-kappaB at the crossroads of life and death", Nat Immunol, 3(3), pp.221~227 (2002)
- Yamamoto Y, "Therapeutic potential of inhibition of the NFkappa B pathway in the treatment of inflammation and cancer", J Clin Invest, 107(2), pp.135~142 (2001)